UK Radioligand Therapy Market Insights for Healthcare Innovation
The UK Radioligand Therapy (RLT) Market growth continues to accelerate as radiopharmaceutical manufacturing and Good Manufacturing Practice infrastructure scales to meet expanding clinical demand across the NHS and private sectors. With radioligand therapy requiring on-site or nearby radiopharmaceutical production due to short radionuclide half-lives, the demand for UK-based GMP radiopharmacy...
0 Comments 0 Shares 171 Views 0 Reviews